LamdaGen Corporation is a leading technology company specializing in the development and integration of powerful plasmonic biosensors. We are dedicated to enabling rapid point-of-use diagnostic and detection systems that offer exceptional sensitivity and precise quantitation. Our flagship product, the LAuRA Digital Diagnostic System, utilizes our proprietary plasmonic biosensors as its core technology, supported by our groundbreaking Plasmonic Amplification Technology™ (PAT™).

What sets us apart is our unique double amplification system, which combines the convenience and speed of lateral flow assay technologies with the exceptional sensitivity and quantitation capabilities of microtiter plate enzyme-linked immunosorbent assays. This breakthrough technology allows us to provide cutting-edge products that aid in food and water safety, human health, animal health, and environmental health. At LamdaGen, we follow a serial spin-off licensing model to maximize the value of our biosensor-based technologies.

By partnering with industry leaders in various sectors, we apply our powerful biosensor technology to a wide range of applications, advancing diagnostic capabilities and enhancing overall safety and well-being. Our goal is to continuously push the boundaries of sensitivity, speed, and precision in the field of plasmonic biosensing. Through our innovative detection solutions, we contribute to the improvement of human, animal, and environmental health.

Join us on this mission and be a part of our dedicated team at LamdaGen Corporation